232 related articles for article (PubMed ID: 33743615)
1. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
2. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
5. Radiomic nomogram for discriminating parotid pleomorphic adenoma from parotid adenolymphoma based on grayscale ultrasonography.
Mao Y; Jiang L; Wang JL; Chen FQ; Zhang WP; Liu ZX; Li C
Front Oncol; 2023; 13():1268789. PubMed ID: 38273852
[TBL] [Abstract][Full Text] [Related]
6. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
7. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
8. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
9. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.
Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y
Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128
[TBL] [Abstract][Full Text] [Related]
10. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
11. Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters.
Zhang D; Li X; Lv L; Yu J; Yang C; Xiong H; Liao R; Zhou B; Huang X; Liu X; Tang Z
BMC Med Imaging; 2020 Apr; 20(1):38. PubMed ID: 32293304
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Different Machine Models Based on Multi-Phase Computed Tomography Radiomic Analysis to Differentiate Parotid Basal Cell Adenoma From Pleomorphic Adenoma.
Zheng YL; Zheng YN; Li CF; Gao JN; Zhang XY; Li XY; Zhou D; Wen M
Front Oncol; 2022; 12():889833. PubMed ID: 35903689
[TBL] [Abstract][Full Text] [Related]
13. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
[TBL] [Abstract][Full Text] [Related]
14. MRI-based texture analysis to differentiate the most common parotid tumours.
Sarioglu O; Sarioglu FC; Akdogan AI; Kucuk U; Arslan IB; Cukurova I; Pekcevik Y
Clin Radiol; 2020 Nov; 75(11):877.e15-877.e23. PubMed ID: 32703544
[TBL] [Abstract][Full Text] [Related]
15. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
16. Combined Diagnosis of Whole-Lesion Histogram Analysis of T1- and T2-Weighted Imaging for Differentiating Adrenal Adenoma and Pheochromocytoma: A Support Vector Machine-Based Study.
Liu J; Xue K; Li S; Zhang Y; Cheng J
Can Assoc Radiol J; 2021 Aug; 72(3):452-459. PubMed ID: 32208861
[TBL] [Abstract][Full Text] [Related]
17. Radiomics analysis of T1WI and T2WI magnetic resonance images to differentiate between IgG4-related ophthalmic disease and orbital MALT lymphoma.
Shao Y; Chen Y; Chen S; Wei R
BMC Ophthalmol; 2023 Jun; 23(1):288. PubMed ID: 37353736
[TBL] [Abstract][Full Text] [Related]
18. Application of DTI and ARFI imaging in differential diagnosis of parotid tumours.
Yu J; Du Y; Lu Y; Zhang W; Zhang D; Wang G; Li C
Dentomaxillofac Radiol; 2016; 45(6):20160100. PubMed ID: 27351345
[TBL] [Abstract][Full Text] [Related]
19. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
Zheng Y; Zhou D; Liu H; Wen M
Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
Rong X; Zhu Q; Ji H; Li J; Huang H
Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]